Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Eye irritation

Currently viewing:

Administrative data

Endpoint:
eye irritation: in vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2017-12-04 to 2018-01-01
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2018
Report date:
2018

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 405 (Acute Eye Irritation / Corrosion)
Version / remarks:
2017-10-09
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
signed on 2015-06-05

Test material

Constituent 1
Chemical structure
Reference substance name:
Barium m-toluate
EC Number:
268-460-7
EC Name:
Barium m-toluate
Cas Number:
68092-47-7
Molecular formula:
C8H7O2.1/2Ba
IUPAC Name:
barium m-toluate
Test material form:
solid: particulate/powder
Details on test material:
- State of aggregation: solid, powder
Specific details on test material used for the study:
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: dry; < 30 °C

Test animals / tissue source

Species:
rabbit
Strain:
New Zealand White
Details on test animals or tissues and environmental conditions:
TEST ANIMALS
- Source: Charles River Deutschland, 97633 Sulzfeld, Germany
- Age at study initiation: animal #1: approx. 32 weeks old; animal #2: approx. 34 weeks old
- Weight at study initiation: animal #1: 4.3 kg; animal #2: 4.1 kg
- Housing: individually housed in ABS-plastic or Noryl rabbit cages, floor 4200 cm²
- Diet (ad libitum): autoclaved hay and to Altromin 2123 maintenance diet for rabbits, rich in crude fibre
- Water (ad libitum): tap water
- Acclimation period: at least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature: 18 ± 3 °C
- Relative humidity: 55 ± 10%
- Air changes: at least 10 x / hour
- Photoperiod (hrs dark / hrs light): 12/12

Test system

Vehicle:
unchanged (no vehicle)
Controls:
no
Amount / concentration applied:
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0.1 g of the test item in the conjunctival sac of one eye. Untreated eye served as control.
Duration of treatment / exposure:
1 hour
Observation period (in vivo):
1, 24, 48 and 72 hours as well as 4 to 13 days after test item application
Number of animals or in vitro replicates:
2 female rabbits
Details on study design:
PREPARATION OF THE ANIMALS
Within 24 hours before the test and immediately prior to the application both eyes of each animal were examined.
Approx. 17 hours (one animal) and 18 hours (second animal) before the application the eyes were examined with the aid of a fluorescein solution (Fluoreszein SE Thilo®). The eyes were rinsed with physiological saline 0.9 % NaCl after the examination. None of the animals showed eye irritation, ocular defects, or pre-existing corneal injury.

INITAL TEST AND CONFIRMATORY TEST
The in vivo test was performed initially using one animal. The results of the initial test did not indicate the test item to be corrosive or a severe irritant to the eye using the procedure described. In order to confirm the response, one additional animal was treated in the same manner.

USE OF TOPICAL ANESTHETICS AND SYSTEMIC ANALGESICS
One hour before the application of the test item, 0.01 mg/kg of buprenorphine (Temgesic® 0.3 mg/mL) was administered subcutaneously in order to achieve a therapeutic level of systemic analgesia. Approx. 5 minutes prior to the application of the test item, 1-2 drops of an ocular anaesthetic (Proparakaine-POS® hydrochloride ophthalmic 0.5% solution) were administered in both the treated and the control eye of each animal.
To prevent pain and distress after the application of the test item both animals were treated with doses of buprenorphine and meloxicam (Metacam® 5 mg/mL) to provide a continued therapeutic level of systemic analgesia. Treatment with the analgesic medication was conducted from 11 hours post-application (day 0) upto 6 or 8 days post-application.

REMOVAL OF TEST SUBSTANCE
- Washing: treated eye were rinsed with physiological saline 0.9 % NaCl.
- Time after start of exposure: 1 hour after the application

SCORING SYSTEM: according to Draize scale

TOOL USED TO ASSESS SCORE: slit lamp biomicroscope / fluorescein
To detect cornea lesions the treated eyes were examined with the aid of a fluorescein solution and a slit lamp biomicroscope 24 hours post-application and from then on daily until end of the observation period. The eyes were rinsed with physiological saline 0.9% NaCl after the examination.

OBSERVATIONS
- body weight: prior to the administration and at least at the end of the observation period
- clinical observations: nature, severity and duration were recorded

Results and discussion

In vivo

Resultsopen allclose all
Irritation parameter:
cornea opacity score
Basis:
mean
Remarks:
animal #1
Time point:
24/48/72 h
Score:
1.67
Max. score:
4
Reversibility:
fully reversible within: 9 days
Irritation parameter:
iris score
Basis:
mean
Remarks:
animal #1
Time point:
24/48/72 h
Score:
0.67
Max. score:
2
Reversibility:
fully reversible within: 7 days
Irritation parameter:
conjunctivae score
Basis:
mean
Remarks:
animal #1
Time point:
24/48/72 h
Score:
2
Max. score:
3
Reversibility:
fully reversible within: 13 days
Irritation parameter:
chemosis score
Basis:
mean
Remarks:
animal #1
Time point:
24/48/72 h
Score:
1.67
Max. score:
4
Reversibility:
fully reversible within: 12 days
Irritation parameter:
cornea opacity score
Basis:
mean
Remarks:
animal #2
Time point:
24/48/72 h
Score:
1
Max. score:
4
Reversibility:
fully reversible within: 13 days
Irritation parameter:
iris score
Basis:
mean
Remarks:
animal #2
Time point:
24/48/72 h
Score:
1
Max. score:
2
Reversibility:
fully reversible within: 7 days
Irritation parameter:
conjunctivae score
Basis:
mean
Remarks:
animal #2
Time point:
24/48/72 h
Score:
1.67
Max. score:
3
Reversibility:
fully reversible within: 6 days
Irritation parameter:
chemosis score
Basis:
mean
Remarks:
animal #2
Time point:
24/48/72 h
Score:
1.67
Max. score:
4
Reversibility:
fully reversible within: 7 days
Irritant / corrosive response data:
Animal #1:
- conjunctival redness: slight conjunctival redness (grade 1) was observed one hour post-application and from day 8 until day 12 post-application. In between, from 24 hours until day 7 post-application, a moderate conjunctival redness (grade 2) was detected in the animal. The effect was fully reversible within day 13 after application of the test material.

- conjunctival chemosis: moderate conjunctival chemosis (grade 3) was observed one hour after application, while grade 2 was observed 24 and 72 hours after application. A slight conjunctival chemosis (grade 1) was detected in the animal between 72 hours and day 11 after application. The effect was fully reversible within day 12 after application of the test material.

- iris: slight iris lesion (grade 1) was observed from 48 hours until day 6 post-application. The effect was fully reversible within day 7 after application of the test material.

- cornea opacity: slight corneal opacitiy (grade 1) was found in the animal one hour until 24 hours post-application, morderate corneal opacity (grade 2) was observed from 48 hours until day 6 after application, and slight corneal opacity (grade 1) was found from day 7 until day 8 post-application. The effect was fully reversible within day 9 after application of the test material.

Animal #2:
- conjunctival redness: the animal showed slight conjunctival redness (grade 1) one hour and from 72 hours until 5 days after application and moderate conjunctival redness (grade 2) in between at the 24 hours’ and 48 hours’ post-application time points. The effect was fully reversible within day 6 after application of the test material.

- conjunctival chemosis: moderate conjunctival chemosis (grade 3) was detected in the animal one hour post-application before severity level decreased from 24 until 48 hours post-application (grade 2) and from 72 hours until day 6 post-application (slight conjunctival chemosis; grade 1). The effect was fully reversible within day 7 after application of the test material.

- Iris: slight iris lesion (grade 1) was observed in the animal from 24 hours until day 6 after application. The effect was fully reversible within day 7 after application of the test material.

- corneal opacity: the animal showed slight cornea opacity (grade 1) from one hour until day 12 post-application. The effect was fully reversible within day 13 after application of the test material.


Local effects were observed in both animals. The observed local effects mainly comprise slight to severe hypersecretion, highly reddened nictitating membrane, dark red spots on the nictitating membrane, and white spots on the cornea.
Upon fluorescein examinations starting 24 hours post-application, the treated eye of the animals showed corneal lesions (starting with approx. 75% of the area) which were completely reversible within 9 or 10 days, respectively.
Other effects:
- clinical observations: neither mortalities nor significant clinical signs of toxicity were observed.
- body weight: the body weight development of all animals showed a slight decrease.

Applicant's summary and conclusion

Interpretation of results:
Category 2 (irritating to eyes) based on GHS criteria
Conclusions:
The substance is irritating to the eyes.
According to the EC Regulation No. 1272/2008 and subsequent adaptations, the substance is classified as an eye irritant (Category 2; H319).